pneumonia
common
clinic
entiti
particularli
among
elderli
addit
among
young
children
mani
develop
countri
communityacquir
pneumonia
cap
respons
signific
number
death
million
children
age
kill
pneumonia
everi
year
aid
malaria
measl
combin
child
die
pneumonia
develop
countri
die
develop
countri
identif
etiolog
agent
caus
cap
critic
defin
proper
treatment
introduct
prevent
measur
although
limit
number
pathogen
respons
vast
major
case
wide
varieti
etiolog
agent
may
caus
cap
mani
studi
conduct
investig
bacteri
etiolog
cap
contrast
vast
amount
knowledg
bacteri
agent
viral
etiolog
cap
paid
equival
attent
respiratori
syncyti
viru
rsv
influenza
type
b
viru
flua
flub
rhinoviru
rv
parainfluenza
viru
type
adenoviru
adv
human
metapneumoviru
hmpv
enteroviru
ev
analyz
cap
studi
shown
rsv
rv
common
agent
associ
cap
children
rv
coronavirus
frequent
identifi
adult
patient
sever
acut
respiratori
syndrom
coronaviru
sarscov
strain
influenza
viru
adenoviru
serotyp
also
receiv
focus
attent
caus
sever
lower
respiratori
tract
infect
although
common
microbi
agent
account
major
cap
establish
case
diseas
still
caus
unknown
pathogen
viral
cultur
direct
fluoresc
antigen
detect
dfa
tradit
gold
standard
diagnost
test
respiratori
viral
pathogen
yet
assay
laborintens
timeconsum
advantag
detect
multipl
pathogen
simultan
variou
multiplex
pcr
develop
optim
perform
lower
respiratori
tract
sampl
offer
opportun
increas
sensit
specif
diagnosi
improv
outcom
multiplex
method
broadli
use
detect
common
etiolog
agent
cap
howev
new
inform
incid
atyp
pathogen
pathogen
case
sever
cap
cap
elderli
multiplex
assay
use
detect
mani
pathogen
caus
pneumonia
similar
symptom
method
unambigu
detect
broad
rang
microbi
agent
simultan
highli
demand
resequenc
pathogen
microarray
rpm
singl
highli
multiplex
simultan
differenti
diagnost
assay
furthermor
sequenc
inform
produc
rpm
enabl
achiev
highresolut
pathogen
identif
nearneighbor
discrimin
advantag
compet
technolog
make
rpm
highli
suitabl
outbreak
investig
caus
atyp
pathogen
uncommon
pathogen
studi
nasopharyng
aspir
collect
assess
broadrang
respiratori
tract
viral
agent
detect
abil
new
rpm
design
tessara
llc
institut
viral
diseas
control
prevent
ivdc
chines
center
diseas
control
prevent
ccdc
assay
could
sequenc
bp
strand
target
gene
sequenc
distribut
across
detector
tile
length
repres
typessubtyp
viral
pathogen
respiratori
tract
pathogen
caus
respiratori
infect
virus
target
assay
identifi
materi
consist
influenza
subtyp
rhinovirus
enterovirus
virus
nasopharyng
aspir
npa
consecut
collect
beij
center
diseas
control
prevent
cdc
patient
diagnosi
cap
five
beij
district
gener
hospit
januari
decemb
patient
includ
least
one
follow
symptom
acut
infect
respiratori
tract
diseas
manifest
pneumonia
confirm
chest
radiographi
clinic
diagnosi
pneumonia
patient
fever
chill
chang
distribut
white
blood
cell
wbc
identifi
acut
infect
symptom
respiratori
tract
diseas
may
includ
least
one
follow
cough
without
expector
dyspnea
chest
discomfort
auscultori
lung
find
total
patient
male
meet
criteria
age
month
year
old
enrol
studi
tabl
patient
standard
questionnair
includ
demograph
data
radiolog
result
clinic
sign
fill
npa
kept
studi
aspect
studi
perform
accord
nation
ethic
regul
approv
institut
review
board
centr
diseas
control
prevent
china
well
ethic
committe
beij
cdc
particip
receiv
inform
studi
purpos
right
keep
inform
confidenti
written
consent
obtain
adult
particip
children
parent
guardian
nucleic
acid
extract
purifi
npa
use
masterpur
complet
dna
rna
purif
kit
epicent
technolog
madison
wi
accord
manufactur
recommend
protocol
purifi
nucleic
acid
frozen
aliquot
two
arabidopsi
thaliana
plant
gene
correspond
triosphosph
isomeras
tim
nac
domaincontain
protein
chosen
intern
control
revers
transcript
rt
multiplex
pcr
dna
obtain
plantlet
kindli
provid
chines
academi
scienc
tim
correspond
differ
fragment
tim
correspond
differ
fragment
amplifi
whole
genom
purifi
use
qiaquick
pcr
purif
kit
qiagen
hilden
germani
purifi
product
ligat
pgemt
vector
promega
madison
wi
recombin
plasmid
transform
e
coli
recombin
plasmid
tim
linear
spei
vitro
transcrib
promot
use
larg
scale
rna
product
system
promega
madison
wi
total
copi
vitro
transcrib
tim
rna
copi
plasmid
use
intern
control
check
amplif
effici
rtpcr
multiplex
pcr
well
presenc
inhibitor
specimen
genespecif
primer
pair
design
tessara
llc
institut
viral
diseas
control
prevent
ivdc
ccdc
similar
anneal
temperatur
assur
approxim
amplif
effici
achiev
good
sensit
specif
one
conserv
gene
pathogen
chosen
target
uniqu
primer
check
use
full
search
genbank
databas
blast
program
method
tania
tabon
et
al
adapt
reduc
intraprim
interact
ensur
similar
amplif
effici
ad
linker
sequenc
base
forward
univers
tag
sequenc
utsf
base
revers
univers
tag
sequenc
utsr
end
forward
revers
primer
respect
minim
possibl
potenti
primer
dimer
help
ensur
suffici
amplif
primer
divid
four
independ
reaction
simplifi
primer
design
optim
rt
reaction
perform
volum
contain
datp
dttp
dgtp
dctp
random
hexam
rt
buffer
dtt
rnaseout
superscript
iii
invitrogen
life
technolog
carlsbad
ca
copi
vitro
transcrib
tim
rna
extract
clinic
specimen
reaction
carri
thermo
cycler
thermo
electron
corp
vantaa
finland
use
manufactur
recommend
protocol
aliquot
rt
product
subject
four
differ
multiplex
pcr
primer
mix
contain
primer
pair
correspond
target
gene
common
respiratori
virus
includ
four
adv
serotyp
four
cov
speci
two
rsv
subgroup
two
hmpv
subtyp
four
piv
type
human
bocaviru
hbov
three
influenza
subtyp
one
influenza
b
viru
one
influenza
c
viru
three
rv
serotyp
one
intern
control
see
tabl
materi
primer
mix
b
contain
primer
pair
correspond
target
gene
influenza
subtyp
eight
rv
serotyp
three
piv
type
one
intern
control
see
tabl
materi
primer
mix
c
contain
primer
pair
correspond
target
gene
nine
coxsackieviru
subtyp
three
coxsackieviru
b
subtyp
ten
echoviru
type
three
polioviru
type
three
enteroviru
type
two
intern
control
see
tabl
materi
primer
mix
contain
primer
pair
correspond
target
gene
rsvb
uncommon
respiratori
virus
includ
parvoviru
polyomaviru
toroviru
covsar
parechoviru
aichi
viru
measl
viru
sendai
viru
rubella
viru
mump
viru
poxviru
one
intern
control
see
tabl
materi
pcr
perform
volum
contain
qiagen
multiplex
pcr
master
mix
qiagen
hilden
germani
nm
primer
ut
nm
primer
primer
mix
copi
clone
plasmid
rt
product
applic
reaction
carri
thermo
cycler
thermo
electron
corp
vantaa
finland
initi
incub
activ
hotstar
taq
dna
polymeras
follow
cycl
cycl
cycl
final
extens
product
four
pcr
pool
togeth
subject
purif
process
hybrid
accord
manufactur
recommend
protocol
affymetrix
inc
santa
clara
ca
hybrid
perform
imag
scan
process
previous
describ
produc
fasta
output
file
specif
assay
investig
previous
confirm
posit
specimen
infect
common
respiratori
viru
typessubtyp
target
gene
pathogen
amplifi
specif
primer
use
posit
sampl
product
purifi
ligat
pgemt
vector
promega
madison
wi
construct
recombin
plasmid
rna
virus
plasmid
amplifi
e
coli
linear
spei
vitro
transcrib
promot
use
larg
scale
rna
product
system
promega
madison
wi
rna
copi
number
calcul
measur
purifi
rna
concentr
spectrophotometri
use
eppendorf
biophotomet
eppendorf
ag
hamburg
germani
dna
virus
copi
number
amplifi
plasmid
calcul
measur
plasmid
concentr
use
eppendorf
biophotomet
eppendorf
ag
hamburg
germani
tenfold
serial
dilut
rnadna
templat
known
copi
number
use
evalu
sensit
assay
panel
six
sampl
differ
number
copi
organ
prepar
sampl
test
ten
time
five
day
result
analyz
spss
ibm
corp
calcul
analyt
sensit
evalu
assay
known
pathogen
detect
demonstr
assay
use
retrospect
diagnos
respiratori
infect
set
cap
clinic
sampl
collect
chaoyang
shunyi
fengtai
dongcheng
tongzhou
district
gener
hospit
beij
januari
decemb
use
compar
util
microarraybas
diagnost
gexpbas
multiplex
rtpcr
assay
respiratori
viru
detect
develop
laboratori
specimen
npa
patient
clinic
document
cap
sampl
chosen
randomli
without
test
respiratori
pathogen
lack
cultur
result
concern
upper
respiratori
bacterium
contamin
make
difficult
properli
identifi
bacteri
pathogen
data
pathogen
report
tessarray
sequenc
analysi
tseq
softwar
evalu
score
rpmflu
detector
tile
metric
detect
dna
sequenc
quantiti
qualiti
score
total
number
gseqidentifi
nucleotid
appear
run
three
consecut
nonn
base
call
express
percentag
length
nucleotid
rpmflu
detector
tile
sequenc
relax
stringent
target
pathogen
detect
report
threshold
rpmflu
assay
statist
empir
establish
resequenc
detector
tile
score
score
respect
studi
threshold
score
increas
due
shorten
detector
tile
sequenc
complic
background
inher
clinic
sampl
new
method
compar
multiplex
pcr
assay
parallel
detect
common
sixteen
human
respiratori
viru
typessubtyp
virus
identifi
posit
detect
refer
assay
convent
pcr
sequenc
perform
specif
confirm
predetermin
clinic
sampl
tabl
figur
show
raw
data
imag
gener
hybrid
influenza
type
b
viru
target
amplicon
process
sequenc
data
imag
provid
materi
materi
figur
show
align
segment
assay
detect
sequenc
correspond
gene
detector
tile
sequenc
noninterf
hybrid
name
hybrid
nontarget
amplicon
detect
result
nonspecif
base
call
occur
target
probe
set
insuffici
caus
incorrect
identif
base
call
gener
noninterf
hybrid
mostli
observ
rvev
utr
influenza
viru
flu
gene
differ
type
subtyp
sequenc
gener
noninterf
hybrid
caus
misidentif
noninterf
hybrid
distinguish
hybrid
intend
target
sensit
assay
evalu
use
serial
dilut
vitro
transcrib
rna
dna
clone
lowest
detect
dilut
reveal
individu
sensit
rang
copi
per
reaction
viru
typessubtyp
data
shown
limit
detect
lod
adv
speci
use
probit
regress
analysi
shown
tabl
tabl
respect
similarli
detect
limit
time
detect
viru
typessubtyp
calcul
use
probit
analysi
tabl
compar
sensit
standard
multiplex
pcr
method
evalu
abil
assay
identifi
multipl
pathogen
simultan
combin
common
respiratori
viru
templat
cdna
dna
mix
concentr
prepar
panel
serial
dilut
nucleic
acid
templat
templat
contain
gene
copi
per
reaction
pathogen
use
assess
detect
sensit
specif
multipl
pathogen
result
reveal
approach
allow
simultan
detect
pathogen
titer
copiesreact
probit
analysi
perform
limit
detect
calcul
analyt
sensit
tabl
result
indic
assay
effect
mean
detect
type
variou
pathogen
high
sensit
specif
even
mani
sixteen
pathogen
simultan
present
addit
abil
identifi
multipl
pathogen
simultan
determin
dilut
one
two
pathogen
repres
situat
analog
actual
clinic
sampl
especi
identifi
coinfect
use
combin
rsva
copiesreact
adv
copiesreact
probit
analysi
result
show
could
detect
pathogen
limit
copiesreact
adv
similar
experi
combin
adv
rsva
also
demonstr
high
concentr
target
would
outcompet
lowconcentr
target
present
specimen
data
shown
data
detect
differ
virus
shown
tabl
viral
etiolog
found
patient
viral
speci
identifi
frequent
detect
viru
rv
patient
patient
patient
adv
patient
patient
rsva
patient
patient
seven
patient
viral
find
coinfect
rv
viru
rsvb
hmpv
detect
result
complet
coincid
parallel
refer
assay
tabl
rsva
rpm
detect
specif
one
falseneg
produc
addit
rpm
assay
detect
three
case
season
infect
two
adv
one
refer
method
tabl
improv
sensit
mainli
obtain
multipl
primer
pair
increas
probabl
amplif
thu
achiev
better
effici
similar
situat
occur
human
rhinoviru
detect
rv
detect
rpm
atyp
pathogen
detect
refer
assay
posit
specimen
identifi
rpm
confirm
pcr
sequenc
group
children
age
year
patient
viral
infect
rate
higher
among
patient
age
year
adult
group
respect
figur
previou
version
rpm
valid
show
excel
correl
refer
assay
studi
need
develop
valid
novel
improv
assay
use
technolog
specif
amplif
strategi
protocol
design
primer
amplif
novel
target
need
allow
widespread
clinic
adopt
new
tool
broadrang
detect
microarray
use
direct
detect
microb
complex
sampl
therefor
requir
nucleic
acid
amplif
bring
target
concentr
detect
level
studi
target
multiplex
pcr
base
temperatureswitch
pcr
tsp
amplif
technolog
adopt
commonli
use
multiplex
pcr
reagent
use
increas
assay
sensit
compar
convent
amplif
strategi
case
sampl
heavi
background
eg
human
bacteri
genom
biphas
pcr
paramet
tsp
allow
multiplex
pcr
perform
standard
pcr
condit
without
extens
optim
individu
pcr
assay
uniqu
buffer
multiplex
kit
promot
stabl
effici
primer
anneal
prevent
nonspecif
primer
anneal
templat
increas
local
concentr
primer
templat
allow
effici
extens
improv
therefor
made
easi
group
pathogen
subset
effici
amplif
without
much
optim
allow
stabl
perform
new
primer
ad
primer
mix
primer
chang
combin
target
multiplex
pcr
microarray
hybrid
allow
good
analyt
sensit
case
sampl
heavi
background
abil
differenti
viru
type
subtyp
reli
sequenc
obtain
target
amplicon
hybrid
detector
tile
thu
although
complet
novel
respiratori
pathogen
would
captur
approach
mutant
viru
uncommon
pathogen
could
captur
anoth
benefit
associ
target
multiplex
pcr
resequenc
microarray
simultan
detect
character
sever
virus
allow
signific
timesav
compar
convent
assay
sequenc
could
import
element
improv
emerg
respons
capac
anoth
improv
versu
standard
detect
tool
comprehens
coverag
target
organ
allow
contrast
dedic
target
ha
na
allel
avian
influenza
virus
new
resequenc
array
design
allow
coverag
respiratori
viral
pathogen
two
main
chang
new
microarray
design
compar
length
detector
tile
primer
select
amplif
chosen
target
shorten
detector
tile
allow
increas
number
probe
set
place
microarray
therefor
almost
common
respiratori
viral
pathogen
could
detect
singl
assay
atyp
respiratori
pathogen
eg
measl
viru
rubella
viru
influenza
c
viru
nonrespiratori
viru
eg
hhv
could
detect
probe
correspond
present
furthermor
new
technolog
use
one
pair
primer
design
amplif
conserv
region
allow
rapid
effici
strainlevel
identif
pathogen
may
critic
outbreak
investig
addit
improv
amplif
method
primer
design
new
intern
control
use
two
arabidopsi
thaliana
gene
tim
select
intern
control
plant
gene
would
unlik
occur
natur
clinic
sampl
compar
new
overlap
detector
tile
control
tile
new
microarray
new
primer
design
amplifi
shorter
detector
sequenc
could
improv
hybrid
effici
result
show
base
call
rate
tim
could
reach
without
interfer
detect
microbi
agent
result
new
intern
control
unqualifi
chip
without
base
call
may
found
thu
avoid
falseneg
result
number
target
need
valid
depend
intend
purpos
studi
control
strain
febril
respiratori
ill
fri
caus
pathogen
differ
refer
strain
influenza
viru
use
assess
perform
rpm
respect
studi
sixteen
singleviru
infect
refer
specimen
use
evalu
new
microarray
result
show
excel
specif
new
microarray
type
strainlevel
identif
refer
sampl
new
resequenc
microarray
design
smaller
previou
version
increas
hybrid
effici
length
detector
tile
much
shorter
number
tile
rel
limit
consequ
conserv
gene
sequenc
obtain
detector
tile
pathogen
could
differenti
sampl
strain
level
virus
hmpv
rsva
rsvb
addit
virus
mani
serotyp
thu
identif
could
achiev
speci
level
adv
rv
result
show
excel
correl
refer
assay
detect
common
respiratori
pathogen
one
falseneg
rsva
sinc
one
addit
occurr
infect
two
adv
sixteen
rv
three
flua
two
detect
new
assay
increas
sensit
assay
compar
refer
method
like
attribut
use
multipl
conserv
primer
pair
target
specif
pathogen
high
effici
assay
particularli
notic
rv
identif
rpmidentifi
rv
infect
detect
refer
assay
use
twelv
rv
typespecif
primer
pair
rpm
primer
mix
compar
one
pair
refer
assay
like
enabl
improv
detect
rv
detect
rate
common
virus
consist
previou
research
commonli
detect
viru
children
age
year
rsv
detect
rsv
type
common
etiolog
agent
adult
group
rv
infect
cluster
within
type
analysi
detectionposit
patient
complet
clinic
data
signific
season
predomin
observ
total
number
viru
detect
compar
previou
studi
neither
obviou
differ
detect
rate
observ
among
group
variou
diseas
sever
due
broad
detect
extent
aetiolog
anetiolog
viru
small
sampl
size
result
broad
rang
respiratori
virus
identifi
assay
atyp
pathogen
detect
use
new
microarray
one
instanc
measl
viru
one
rubella
viru
one
influenza
type
c
infect
found
patient
age
year
year
month
respect
rubella
viru
pathogen
agent
rubella
common
childhood
infect
could
affect
anyon
age
possibl
complic
fatal
pneumonia
caus
agent
measl
presenc
measl
viru
may
also
lead
seriou
problem
includ
measl
pneumonia
lifethreaten
complic
children
influenza
c
viru
sometim
present
patient
clinic
diagnosi
pneumonia
could
caus
varieti
respiratori
ill
clinic
differenti
caus
virus
hhv
ubiquit
human
caus
lifelong
infect
primari
infect
usual
occur
childhood
viru
remain
latent
ganglia
sensori
neuron
system
stimuli
includ
fever
due
bacteri
viral
infect
caus
reaction
viru
potenti
clinic
diseas
result
activ
secret
throat
although
report
symptomat
pulmonari
involv
directli
attribut
hhv
infect
presenc
hhv
throat
still
highli
signific
independ
risk
factor
develop
lower
respiratori
tract
infect
hhv
sequenc
tile
instanc
ebv
cmv
infect
detect
use
rpm
method
subsequ
confirm
pcr
sequenc
patient
infect
hhv
coinfect
anoth
one
coinfect
viru
caus
roseola
fever
primari
infect
identifi
three
children
age
one
age
sampl
specimen
adult
patient
frequenc
hhv
npa
adult
patient
lower
found
previou
studi
might
due
differ
sampl
characterist
although
possibl
retrospect
studi
without
concomit
detect
bacteri
pathogen
state
atyp
pathogen
caus
agent
result
studi
show
capabl
detect
atyp
pathogen
potenti
diagnos
infecti
syndrom
manifest
similar
symptom
caus
divers
etiolog
agent
accur
identif
multipl
respiratori
tract
viral
pathogen
use
studi
demonstr
novel
assay
could
improv
respons
capac
epidem
outbreak
signific
tool
public
health
howev
falseneg
detect
rsva
address
prior
clinic
adopt
capabl
assay
simultan
detect
broadspectrum
respiratori
tract
virus
also
valid
consid
applic
new
rpm
toward
outbreak
investig
epidem
surveil
